CHERYL BITTING: Open Payments
NPI 1891888301 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$310 in 13 payments from 9 companies in 2025. Trend: 2023 $41 · 2024 $21 · 2025 $310
Food & beverage: $310
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $76 |
| Novartis Pharmaceuticals Corporation | 2 | $58 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Calliditas Therapeutics US Inc. | 1 | $38 |
| Travere Therapeutics, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
| OPKO Pharmaceuticals, LLC | 1 | $20 |
| Amgen Inc. | 1 | $19 |
| Vifor Pharma, Inc. | 1 | $16 |
Products named: BENLYSTA, Fabhalta, TARPEYO, JARDIANCE, VOYXACT, RAYALDEE, UPLIZNA, JYNARQUE.
Industry payments across PA — which companies pay providers there.
